Creating a program to help liver transplant patients recover from alcohol use disorder
Official title: Development and Testing of an Integrated Care Coordination Intervention for Alcohol Use Disorder Recovery after Liver Transplantation
Funded at Massachusetts General Hospital · NIH-10912818 · Data updated 2026-11-12
This study is testing a new support program for people who have received a liver transplant and are dealing with alcohol use issues, helping them stay on track with their recovery through community health workers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $197,640 |
| NIH project number | 5K23AA031068-02 |
| Project ID | NIH-10912818 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are liver transplant recipients who have a history of alcohol use disorder.
✕Less likely to help
Patients who do not have a history of alcohol use disorder or who are not liver transplant recipients may not benefit from this research.
What this research studies
This research focuses on developing and testing a new program designed to support liver transplant recipients who struggle with alcohol use disorder. The program, known as the Integrated Liver Transplant and Alcohol Recovery Program (ILTARP), aims to provide coordinated care through community health workers who will assist patients in preventing relapse and managing their recovery. The research will involve collaborating with experts and stakeholders to refine the program, followed by a pilot study to evaluate its feasibility and effectiveness in a clinical setting. By addressing the unique challenges faced by these patients, the research seeks to improve their overall health outcomes post-transplant.
Why it matters
Potential benefit: If successful, this research could significantly improve recovery rates and quality of life for liver transplant patients with alcohol use disorder.
How similar studies have gone: While there is limited evidence-based intervention specifically for this population, similar integrated care approaches have shown promise in other areas of addiction recovery.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: Dageforde, Leigh Anne — Massachusetts General Hospital
- Study coordinator: Dageforde, Leigh Anne
Related research
Other NIH-funded projects on the same topics.
-
Functional Connectivity-Guided TMS for Alcohol Use Disorder
A new approach uses targeted brain stimulation to help people with alcohol use disorder stay abstinent longer by focusing treatment on specific brain circuits.
-
Alcohol Use Disorder and Suicidal Behavior: Finding Why They Occur Together
A study using Swedish population data to understand why alcohol use disorder relates to suicidal thoughts and acts, with the goal of improving risk prediction and prevention.
-
Non-hallucinogenic psilocybin derivative for alcohol use disorder
A new, safer psilocybin-like compound is being studied to help people with alcohol use disorder.
-
Identifying brain proteins linked to PTSD and alcohol use disorder
Researchers are studying brain proteins that may contribute to PTSD and alcohol use disorder in US veterans to find new ways to help people who struggle with both conditions.
-
Mu and Kappa Opioid Balance in Alcohol Use Disorder
A study using brain imaging to understand how the brain’s opioid system changes during early sobriety in adults with alcohol use disorder.
-
Telehealth support to prevent suicide in people with alcohol use disorder in Tanzania
A telehealth counseling program is being adapted to help reduce suicide risk for people with alcohol use disorder in emergency departments in Tanzania.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.